Recent progress in the prevention of serogroup B meningococcal disease
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease. Over a period of four decades vaccine development has focused on sub-capsular, protein antigens, first with outer membrane vesicle (OMV) vaccines a...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Published: |
American Society for Microbiology
2017
|